Ultra-low temperature freezers (typically referring to equipment with a temperature of -86°C) play a critical role in blood and organ preservation. Their core function is to inhibit biological activity reactions through an extremely low-temperature environment, thereby extending the stability and usability of samples. The following details the specific application scenarios and technical essentials of ultra-low temperature freezers in blood and organ preservation.

I. Preservation of Blood Samples
1. Preservation of Whole Blood and Blood Components
- Red Blood Cell Storage: Requires freezing preservation at temperatures below -80°C (with glycerol added as a cryoprotectant). This can maintain the structure of hemoglobin and its oxygen-carrying capacity over a long period, making it suitable for the storage of rare blood types.
- Platelets and White Blood Cells: Need to be rapidly frozen to below -150°C (usually using liquid nitrogen tanks) to prevent ice crystals from damaging the cell membrane and to extend their in vitro survival time.
- Plasma and Serum: Preserved at -20°C to -80°C to prevent protein denaturation or degradation, and are used for infectious disease detection, hormone analysis, etc.
2. Special Blood Products
- Stem Cells and Immune Cells: For example, T cells in CAR-T cell therapy need to be cryopreserved at -196°C in liquid nitrogen to maintain cell viability and function.
- Viral Vectors and Gene Therapy Materials: Such as lentiviral vectors, which require ultra-low temperature storage to prevent degradation by nucleases.
3. Technical Challenges and Solutions
- Prevention of Freezing Injury: Control the cooling rate (e.g., 1°C/min) using a programmable cooling instrument, and add cryoprotectants such as dimethyl sulfoxide (DMSO).
- Guarantee of Temperature Stability: Adopt a dual-compressor system or a liquid nitrogen backup to ensure that the temperature fluctuation is less than ±2°C during power outages.
II. Preservation of Organs and Tissues
1. Short-Term Preservation Before Organ Transplantation
- Heart, Liver, and Kidney: Typically preserved using 4°C refrigerated containers for short-term (several hours to 24 hours) storage. However, ultra-low temperature technologies (e.g., -4°C to -10°C) are being explored to extend the preservation time.
- Corneal and Skin Grafts: Require freezing preservation below -80°C to reduce the immune rejection response.
2. Long-Term Tissue Bank Management
- Tumor Tissue Samples: Used for genomic analysis in cancer research, and need to be stored at -80°C to avoid RNA/DNA degradation.
- Bone and Cartilage Transplant Materials: Maintain the integrity of tissue structures through freeze-drying or low-temperature preservation (-70°C).
3. Application of Emerging Technologies
- Vitrification Preservation: Utilize high-concentration cryoprotectants (e.g., ethylene glycol) combined with ultra-rapid cooling (>1000°C/min) to make organs enter a glassy state instead of a crystalline state, reducing mechanical damage. This technology has been applied in oocyte preservation and is expected to extend to solid organs in the future.
- Nanoscale Cryopreservation: Improve the cooling uniformity of large-volume organs through nanoparticle-assisted heat conduction.

III. Quality Control and Regulatory Requirements
1. Temperature Monitoring
- Equipped with continuous temperature recorders (compliant with GLP specifications) to monitor in real-time and alarm abnormal fluctuations.
- Regularly calibrate equipment to ensure compliance with AABB (American Association of Blood Banks) or ISO standards.
2. Sample Traceability System
- Use barcodes or RFID tags to manage sample information, linking patient data with experimental results.
3. Emergency Measures
- Configure backup power supplies (UPS + generators) and redundant storage in liquid nitrogen tanks to cope with sudden power outages or equipment failures.
IV. Typical Cases
- Cold Chain for COVID-19 Vaccines: mRNA vaccines need to be transported and stored in ultra-low temperature freezers at -70°C to ensure the stability of mRNA encapsulated in lipid nanoparticles.
- Establishment of Bone Marrow Banks: Global bone marrow donor databases (such as NMDP) rely on -196°C liquid nitrogen banks for the long-term preservation of hematopoietic stem cells.
![]()
Conclusion
Ultra-low temperature freezers provide reliable guarantees for blood and organ preservation through precise temperature control, anti-freeze protection, and intelligent management. With technological advancements (such as frost-free design and IoT remote monitoring), their applications will become more extensive, playing a key role especially in the fields of regenerative medicine and personalized healthcare.